European Pharmaceutical Review

AUGUST 23, 2022

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. The post Common pharma compliance concerns cited by FDA warning letters appeared first on European Pharmaceutical Review. What can we learn from contamination control failures?

FDA 87

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing 87

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 Every major pharmaceutical manufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly.

Manufacturing 88

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 88

European Pharmaceutical Review

OCTOBER 23, 2023

1 In pharmaceutical manufacturing, the high level of final product quality is the major driver. Tablets should be defect-free and compliant to good manufacturing practice (GMP) aspects and final-user requirements. Pharmaceutical Technology. Internet] IMA Pharma. Fixing Tableting Problems. cited 2023Oct].

Distribution 87

Distribution Food Management Manufacturing 87

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52

Pharma Marketing Media Healthcare 52

World of DTC Marketing

DECEMBER 10, 2020

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. Pharma companies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. In fact, the most recent estimate from the World Customs Organization places the global fake pharma market at $200 billion. But what exactly does this look like? .

Pharmaceutical 78

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 78

World of DTC Marketing

MARCH 15, 2021

SUMMARY : Big pharma is a big business, and nothing motivates big companies more than the potential to earn a lot of money on new products. Big pharma is a huge business with profits that top almost every other industry. Big pharma is a huge business with profits that top almost every other industry.

Pharma 180

Pharma Manufacturing Retail Sales 180